- Home
- NTHI vs ANEB Comparison
NTHI vs ANEB Comparison
Compare NTHI & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTHI
- ANEB
- Stock Information
- Founded
- NTHI 2008
- ANEB 2020
- Country
- NTHI United States
- ANEB United States
- Employees
- NTHI N/A
- ANEB N/A
- Industry
- NTHI Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- NTHI Health Care
- ANEB Health Care
- Exchange
- NTHI Nasdaq
- ANEB Nasdaq
- Market Cap
- NTHI 110.9M
- ANEB 117.1M
- IPO Year
- NTHI N/A
- ANEB 2021
- Fundamental
- Price
- NTHI $5.12
- ANEB $2.50
- Analyst Decision
- NTHI
- ANEB Buy
- Analyst Count
- NTHI 0
- ANEB 2
- Target Price
- NTHI N/A
- ANEB $8.00
- AVG Volume (30 Days)
- NTHI 320.0K
- ANEB 1.2M
- Earning Date
- NTHI 01-01-0001
- ANEB 09-24-2025
- Dividend Yield
- NTHI N/A
- ANEB N/A
- EPS Growth
- NTHI N/A
- ANEB N/A
- EPS
- NTHI N/A
- ANEB N/A
- Revenue
- NTHI $79,990.00
- ANEB N/A
- Revenue This Year
- NTHI N/A
- ANEB N/A
- Revenue Next Year
- NTHI N/A
- ANEB N/A
- P/E Ratio
- NTHI N/A
- ANEB N/A
- Revenue Growth
- NTHI 13.52
- ANEB N/A
- 52 Week Low
- NTHI $3.20
- ANEB $0.80
- 52 Week High
- NTHI $25.00
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- NTHI N/A
- ANEB 55.36
- Support Level
- NTHI N/A
- ANEB $2.22
- Resistance Level
- NTHI N/A
- ANEB $2.66
- Average True Range (ATR)
- NTHI 0.00
- ANEB 0.20
- MACD
- NTHI 0.00
- ANEB -0.08
- Stochastic Oscillator
- NTHI 0.00
- ANEB 28.78
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.